![](https://etimg.etb2bimg.com/thumb/msid-112162327,imgsize-42460,width-1200,height=765,overlay-ethealth/pharma/financial-performance/grifols-takes-494-mln-writedown-on-chinese-investment.jpg)
Grifols takes $494 mln writedown on Chinese investment
By Inti Landauro Madrid: Spanish drugmaker Grifols has taken a 457 million euros ($494 million) writedown on its accounts for 2020 through 2023, to reflect what it says was a previously incorrect accounting treatment of its stake in China's Shanghai …